To study the pathogenicity of murine cytomegalovirus (MCMV) and to identify virulence determinants, we have isolated and phenotypically characterized a set of temperature-sensitive mutants. One mutant, PP269/38, was avirulent for 1-week-old BALB/c mice and restricted in its plaque formation and replication at 39 °C. Mutants PP242/68 and PP268/38 were 100-fold less virulent than salivary gland-grown virus (SGV), even after two passages in the salivary glands of l-week-old mice. The former mutant was unable to replicate or form plaques at 39 °C whereas the latter replicated poorly at 39 °C but not at all at 40 °C although it was able to form plaques at 40 °C with a reduced plaque size. PP31/15 exhibited a 40-fold reduction in virulence compared to SGV after two passages in vivo and was unable to form plaques or to replicate at 40 °C; at 39 °C it was able to, with reduced efficiency. The remaining two mutants, PP99/3 and PP392/31, were 10-fold less virulent than SGV and were restricted at 40 °C. The six mutants have been classified into at least four complementation groups. These mutants may be useful for studying various aspects of MCMV pathogenicity.
INTRODUCTION
Although cytomegalovirus (CMV) normally produces a subclinical infection it has been associated with a wide spectrum of human disease, including developmental anomalies, hepatitis, infectious mononucleosis, pneumonitis, myocarditis and medical problems involving the central nervous system, which may be serious and even fatal (Alford & Britt, 1985; Griffiths & Grundy, 1988) . These problems arise predominantly in immunologically immature (foetus and neonate) or compromised (allograft recipients, patients with AIDS) individuals (Alford & Britt, 1985; Glenn, 1981 ; Macher et al., 1983) . CMV is thus a major human pathogen yet little is known of the mechanisms involved in the production of the various associated diseases or in latency, reactivation or immunosuppression. Such knowledge is a necessary prerequisite for effective immunization or drug therapy.
Many of the difficulties arise because of the strict species specificity of CMVs such that animal experiments with the human virus cannot be accomplished. Most studies of pathogenicity have therefore used animal models such as the mouse (Hudson, 1979; Osborn, 1982) , guinea-pig (Griffith et al., 1985) and rat (Meijer et al., 1986) with their homologous viruses. Murine CMV (MCMV) in mice is a convenient virus-host model in which to study aspects of pathogenesis because subclinical and latent infections occur and the latter may be reactivated following various treatments (Hudson, 1979; Osborn, 1982) . MCMV may also cause immunosuppression and pneumonitis (see Griffiths & Grundy, 1987) .
Generally two model systems have been investigated. First, susceptible and resistant mouse strains have been compared using mouse-passaged cytomegalovirus. Although the mechanisms involved in such resistance are not completely understood it appears not to be immunologically mediated but to depend upon and reflect cellular susceptibility, which is interferon (IFN)-0000-8950 © 1989 SGM dependent in mice with the H-2 k genetic background and IFN-independent when associated with C57BL background genes (Shellam et al., 1983; Shellam & Flexman, 1986; Griffiths & Grundy, 1987; Quinnan & Manischewitz, 1987) . Secondly, passage of MCMV in mouse embryo fibroblasts (MEFs) in vitro leads to reduced virulence for mice and thus salivary gland-passaged (virulent) virus (SGV) has been compared with tissue culture-passaged (attenuated) virus. However this approach, like the first, tells us little about virulence determinants, because the virulence of MCMV is lost or regained on a single passage in cultured cells or in salivary glands, presumably owing to phenotypic rather than genetic changes in the virus (Osborn & Walker, 1971 ; Eizura & Minamishima, 1979; Selgrade et al., 1981 ; Jordan & Takagi, 1983) . Apparently only SGV is virulent (Jordan & Takagi, 1983) since it becomes coated in a non-neutralizing antibody (Chong et al., 1981 ; Inada et al., 1985; Inada & Mims, 1985) inhibiting neutralization by a neutralizing antibody and inhibiting the susceptibility of (and presumably uptake by) macrophages (Inada & Mires, 1985) .
Thus one factor contributing to the lack of knowledge of MCMV virulence is the absence of genetically stable virus strains of differing virulence for use in the murine model. The aim of the present study was to produce attenuated strains by mutagenesis of virulent SGV with N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) and selection of temperature-sensitive (ts) mutants. Such mutants have been prepared with reduced virulence even after passage in the salivary glands of mice. Their preparation and properties are described.
METHODS

Animals.
One-and 3-week-old specific pathogen-free CD1 outbred mice and BALB/c inbred mice used throughout this study were obtained from the School breeding stocks.
Cells. Primary MEF cells were prepared by the trypsinization of foetuses from 16-day pregnant CD1 mice. Cells were grown in Eagle's MEM (EMEM) supplemented with 10~ newborn bovine serum, 0.11~ sodium bicarbonate, 2 mM-L-glutamine, 100 units (U) penicillin per ml and 100 ~tg streptomycin per ml (growth medium). For both virus growth and plaque assay secondary cell cultures were used.
Viruses. The strain of MCMV SGV used throughout this study was kindly supplied by Professor C. A. Mires (Department of Microbiology, United Medical and Dental Schools of Guy's and St. Thomas' Hospitals, Guy's Campus, London Bridge, U.K.). The virus was originally received from DrJ. Osborn (Department of Medical Microbiology, University of Wisconsin, Madison, Wis., U.S.A.) who had developed it from the Smith strain after many passages in mouse salivary gland (Mires & Gould, 1979) . It was further passaged twice in this laboratory in 3-week-old CD1 mice, and the salivary glands were harvested, on each occasion, 2 to 3 weeks after intraperitoneal (i.p.) inoculation of 102 p.f.u, of virus. Tissues were homogenized in a small volume of EMEM (growth medium) using a Sorvall Omnimixer as described previously (Sweet et al., 1977) to give 10~ suspensions. These were clarified by low speed centrifugation (2500 g, 10 min, 4 °C), ultrasonicated for 10 s in a sonicating water-bath, stabilized with a final concentration of 10~ DMSO and stored at -70 °C. Stock virus prepared in this way contained i06 to 107 p.f.u./ml.
The cell-grown virus was the Smith strain of MCMV (Tc) originally obtained from the American Type Culture Collection and again kindly supplied by Professor M ims (Chong et al., 1981) ; it had been passaged 10 to 20 times in cell culture. This was further passaged twice in MEF cells at a low m.o.i. (approx. 0.1 p.f.u./cell). Cell culture fluids were sonicated and filtered (0.22 ~m) before use to remove multicapsid virions, which are present in tissue culture-grown virus but not in SGV (Hudson et al., 1976a; Tonari & Minamishima, 1983; Weiland et al., 1986) .
A ts mutant (ts6) and two acyclovir-resistant mutants (3A and 6A) of the Smith strain of MCMV were kindly provided by Dr G. R. Sandford, The Oncology Center, The Johns Hopkins Medical Institution, Baltimore, Md., U.S.A. The method of their isolation has been described (Sandford et al., 1985; Sandford & Burns, 1988) . Cell-and salivary gland-grown stocks were prepared as described above.
Titration of viruses. Dilutions of stock virus in EMEM with supplements (growth medium) were inoculated onto monolayers of MEF ceils in 24-well Nunc Multidishes (Gibco). After 60 min adsorption at 33 °C, the cultures were overlaid with EMEM containing 49/oo newborn bovine serum, 0.11 ~ sodium bicarbonate, 2 mM-L-glutamine, 100 U/ml penicillin, 100 ktg/ml streptomycin (maintenance medium) and 1 ~ carboxymethyl cellulose (CMC) (overlay medium). The multidishes were incubated in a humid atmosphere of 5 ~ CO2/95 ~ air, in sealed boxes completely submerged in water-baths at 33 °C (permissive temperature), or at 39 °C or 40 °C (non-permissive temperatures), as required. The overlay was removed 6 days after infection, the cultures were stained with formalinized crystal violet and plaques (mean of three replicates) were counted on a Nikon TMS inverted microscope. Titres are expressed as logt0 p.f.u./ml.
Mutagenesis of salivary gland-grown virus.
SGV was cloned twice in MEF cells using terminal dilution and overlay medium as described by Chong et al. (1981) . Medium from wells containing a single plaque was immediately inoculated onto fresh cultures to produce stocks of cloned virus. MEF cells inoculated with cloned virus at an m.o.i, of 0-1 p.f.u./ml were treated with MNNG (2.5 to 40 ~g/ml) 72 and/or 96 h post-infection (p.i.) and culture fluids were harvested as mutagenized stocks 6 days p.i. when infected but untreated cells (control) showed 100K c.p.e. These mutagenized stocks were ultrasonicated and filtered as above. The mutagenized stocks were then examined for ts virus in one of the three different ways. Firstly, mutagenized virus was cloned at 33 °C by limit dilution under a CMC overlay medium as described above. Secondly, virus was cloned as above except that the multiplates were incubated for 2 days at 33 °C followed by 4 days at 39 °C before wells containing small plaques were harvested. Thirdly, mutagenized virus was cloned using maintenance medium containing 0.9 ~ agar Noble (Difco) as the overlay and small plaques present after 2 days incubation at 33 °C and 4 days at 39 °C were 'picked' into EMEM using the drawn-out tip of a Pasteur pipette; plaques were visualized by staining with 0.01% neutral red in phosphate-buffered saline followed by incubation at 37 °C for 6 h, or overnight. In each case the clone was grown up to produce a cloned stock and examined for the ability to form plaques at 33 °C, 39 °C and 40 °C. Viruses which showed little or no ability to form plaques at non-permissive temperatures were cloned again by the same procedure with or without a temperature shift.
Complementation tests. Monolayers of MEF ceils in microtitre plates were infected with pairs of mutants at a multiplicity of 1 to 3 p.f.u./cell for each mutant (i.e. a combined multiplicity of 2 to 6 p.f.u./cell). In parallel, MEF cells were infected with each mutant separately at a multiplicity of 1 to 3 p.f.u./cell. The infected cells were incubated at 39 °C for 4 to 7 days and the harvested virus was assayed at 33 °C after sonication and filtration. The complementation index (CI) was calculated according to the formula: CI, combined yield (A × B)339~C/yield A~9: c + yield 39°c
B33oc, where A and B refer to titres of different strains of ts mutants grown at 39 °C (superscript temperature) and assayed at 33 °C (subscript temperature) (Wicker & Gunther, 1988) . Complementation was considered positive when the CI was higher than 2.
Virulence assay. The susceptibility of suckling (1-week-old) BALB/c mice to MCMV infection was determined by i.p. inoculation of groups of eight to t0 mice with serial twofold dilutions of virus. The LDs0 was calculated by the method of Reed & Muench (1938) .
RESULTS
Replication of MCMV in mouse embryo fibroblasts and treatment with MNNG
To ascertain the optimum time for treatment with MNNG, cells were inoculated at an m.o.i. of 0.2 and yields titrated daily for 5 days p.i. Yields increased exponentially from 72 h p.i. with titres 6.6 × 10 z, 3.4 x 104 and 9.8 × l0 s p.f.u./ml at 72, 96 and 120 h p.i. respectively, at which point > 90~ c.p.e, was observed. Treatment of virus-infected cells was therefore attempted at 72 h and/or 96 h p.i. and yields were measured at 120 h p.i. The most effective protocol for reducing yields by > 90~ was a single treatment with 10 p,g/ml at 96 h p.i. or treatment at 72 h p.i. with 10 ~tg/ml followed by a similar dose at 96 h p.i. (data not shown). Consequently attempts were made to isolate mutants using both these protocols.
Characterization of mutants
Considerable difficulty was encountered in attempts to isolate mutants by the limit dilution selection at 33 °C of single plaques following mutagen treatment. Several promising clones were not confirmed by retitration or recloning. This may have been due to virus aggregation or to the production of multicapsid virions (Hudson et al., 1976a; Weiland et al., 1986) . However sonication and filtration through 0.22 ~tm filters, shown to be effective elsewhere (Tonari & Minamishima, 1983) , did not produce a ts mutant from > 100 clones tested. Neither was success achieved following selection of single small plaques after a temperature shift to 4 days at 39 °C after 2 days incubation at 33 °C. However when plaques were 'picked' using agar instead of CMC in the overlay and the temperature was shifted from 33 °C to 39 °C as above, a total of six ts mutants were isolated from 395 picked plaques. Each of these mutants showed different ts characteristics. Two mutants, PP242/68 and PP269/38, were considerably restricted (80-to 200-fold) in their ability to form plaques [efficiency of plaquing (e.o.p.), 5 x 10 -3 and 1.3 × 10 -z respectively] and replicate (800-to 1200-fold) [efficiency of replication (e.o.r.), 1.3 x 10 -3 and 7.9 × 10 -4 respectively] at 39 °C (Table 1) . A further ts mutant (PP31/15) was inhibited in its ability to form plaques at 39 °C but was considerably restricted (300-fold) only at 40 °C whereas ¶ An underestimate, as c.p.e, was seen in discrete areas at low dilutions but not as plaques.
its replication was restricted (400-fold) at 39 °C. A similar ts mutant, PP392/31, was restricted in its ability to form plaques (800-fold) and to replicate (20000-fold) at 40 °C only (Table 1) . The remaining two mutants, PP99/3 and PP268/38, showed a marked restriction in their e,o.p, at 40 °C. However there was evidence of replication as discrete areas of cytopathology without real plaques could be seen at low dilutions. In some stocks these areas were evident as very small plaques (Fig. 1 ). These two mutants were, however, considerably restricted in their e.o.r, at 39 °C. Clone PP330/1, twice plaque-purified, was not a ts mutant but was isolated from a pool of MNNG-treated virus and shown to be unrestricted in its e.o.p, at 40 °C; it is included as a control. One other ts mutant (ts6), provided by Dr Sandford, had an e.o.p, of 1.6 x 10 -4 at 40 °C agreeing with published data (Sandford & Burns, 1988) . The two acyclovir-resistant mutants showed e.o.p, and e.o.r, values similar to those of wild-type virus (Table 1 ). All mutants were relatively non-leaky at their non-permissive temperatures (Table 1) .
Virulence to mice of wild-type and mutant virus
The p.f.u./ml and p.f.u./LDso of the various parental and mutant viruses grown as stocks in cell culture (passage number 0) and after one and two passages in mice are shown in Table 2 . Mouse stocks were prepared by i.p. inoculation of CD 1 mice with the non-passaged (to produce mouse passage l stock) or mouse-passaged (to produce mouse passage 2) stocks, diluted (~< 10-fold) or undiluted depending upon the titre or virulence of the stock. The LDso of mouse-grown MCMV for 1-week-old BALB/c mice was 30 p.f.u, in agreement with previously published data (SheUam & Flexman, 1986) . Cell-grown parental virus was considerably less virulent (> 2.8 x 10 s p.f.u./LDs0) even after one passage in mice (450 p.f.u./LDs0) and its virulence was little affected by a further mouse passage (Table 2) . Mutant PP269/38, which was restricted in its plaque forming efficiency and replication at 39 °C, was avirulent; that is, attempts to produce mouse-passaged virus were completely unsuccessful (Table 2) . Similar results were obtained with ts6 confirming previous observations (Sandford & Burns, 1988) . Three other mutants, PP31/I 5, PP242/68 and PP268/38, were considerably less virulent than either mouse-grown or cell-grown virus, even after two passages in mice, being 40-to 100-fold less virulent than SGV and four-to 10-fold less virulent than cell-grown virus. Unlike PP269/38 and ts6, these viruses replicated in mice and produced titres of 3.4 x l0 s, 3.1 x l0 s and 6.8 x 104 p.f.u./ml respectively in the salivary glands of CDI mice 3 weeks after i.p. inoculation (Table 2) 3"2 x 10 -3 6-7 × 10 -3 1'8 x 10 -4 3'7 x 10 -4 2"7 × 10 -3 3"8 X 10-1~ 5"0 X 10 -3 1"0 x 10 -2 1"9 x 10 -a 6'8 X 10 -4 2"1 x 10 -3 1"2 × 10 -3 1"3 × t0 -2 1"3 × 10 -3 6"5 X 10 -3 1"4 X 10 -t 6'3 X 10 -1 2'0 X 10 -1 ND 6'3 x 10 -1 ND ND 8.0 × 10 -1 ND ND 1"6 X 10 -4 * These mutants were selected without a temperature shift at the second plaque picking (see Methods). t These mutants did not replicate in mice using the highest inoculum possible.
Discrete areas of c.p.e, sometimes produced by this virus at 40 °C (see Table 1 ) were evident as very tiny plaques in this stock.
§ ND, Not determined.
Complementation group no. PP392/31 were less attenuated than the mutants described above, being of similar virulence to cell-grown virus (Table 2 ). This was reflected in their greater ability to replicate in mice producing salivary gland yields of 1.1 x 106 and 9-2 x 106 p.f.u./ml 3 weeks after inoculation. Acyclovir-resistant mutants (3A and 6A) were also attenuated with respect to mouse-passaged virus but were similar in virulence to cell-grown virus mouse-passaged twice. Clone PP330/1, which had been treated identically to ts mutants except that it was not temperature-restricted, had a virulence similar to wild-type mouse-passaged virus. All ts mutants were still ts in phenotype after two passages in mice (Table 2) .
I
II
Complementation groups
The complementation indices of the ts mutants are shown in Table 3 . Five of the PP mutants were classified into four complementation groups and ts6 formed a fifth group. The other PP mutant, PP269/38, replicated too poorly in vitro and in vivo to produce stocks of sufficient titre for use in complementation assays. Mutants PP242/68 and PP392/31 appeared not to complement each other although they showed different temperatures and efficiencies for restriction of plaque formation and replication (see Table 1 ). Conditions were probably not optimal for determination of complementation as evident by the 4 to 7 days required to detect infectious virus particles. Attempts to improve conditions using centrifugal enhancement of infectivity (Osborn & Walker, 1968; Hudson et al., 1976b) were no more successful.
DISCUSSION
Several ts mutants of human CMV (HCMV) have been isolated and characterized (Yamanishi & Rapp, 1977; Dion & Hamelin, 1987) . Since there is no experimental animal for HCMV, studies have been limited to in vitro analysis. However five ts mutants of MCMV have been described recently (Tonari & Minamishima, 1983; Sandford et al., 1985; Sandford & Burns, 1988) allowing elucidation of the mechanisms of pathogenicity in the mouse. These mutants appear to be avirulent for the mouse, lacking pathogenicity for suckling and/or weanling mice and replicating only briefly and to a limited degree.
In the present communication we describe the isolation and characterization of a further six ts mutants which appear to be more useful than those mentioned above as they fall into four virulence groups. One mutant, PP269/38, is avirulent and behaves like the previously described mutants (e.g. ts6) in that mouse-passaged virus could not be obtained for either mutant (Table 2) . Two mutants, PP242/68 and PP268/38, were restricted in their plaque forming and replication efficiencies at 39 °C and 40 °C respectively and were 90-to 100-fold less virulent than the mousepassaged virulent parent (SGV). Mutant PP31/15 was fully restricted in its e.o.p, and e.o.r, only at 40 °C and was correspondingly less attenuated as it was 40-fold less virulent than SGV (Table  2) . Finally, two mutants, PP99/3 and PP392/31, were of similar virulence to cell-grown virus being 10-fold less virulent than SGV. The reduced virulence observed for all ts mutants does not arise from adaptation to cell growth since viruses mouse-passaged twice were still ts and attenuated. Most probably, it reflects a function of their ts lesions, although the possibility that an unselected mutation other than temperature sensitivity could be involved in the attenuation cannot be excluded. In addition, clone PP330/1, which had undergone the same number of cell and mouse passages from the original SGV but was not ts, was of similar virulence to SGV and was 10-fold more virulent than cell-grown virus. However the six mutants could be assigned to only four complementation groups. PP269/38 replicated too poorly to produce stocks of sufficiently high titre for complementation assays. Two other mutants, PP242/68 and PP392/31, did not complement each other despite having different e.o.p., e.o.r, and restrictive temperatures (Table 1 ). It appears likely, although not proven, that all six mutants have different ts lesions.
Although it has been reported previously that one or two mouse passages of cell-grown virus restores full virulence (Osborn & Walker, 1971 ; Eizura & Minamishima, 1979; Selgrade et al., 1981 ; Jordan & Tagaki, 1983) this was not found in the present study. Virulence of cell-grown virus was increased on passage from >2.8 x 105 p.f.u./LD50 to 450 p.f.u./LDso after one passage and 310 p.f.u./LD50 after two passages but was still considerably less virulent (10-fold) than SGV (Table 2 ). It seems likely that a cell-adapted variant has been selected since the cellgrown virus has now been passaged up to 20 times in MEF cultures (Inada et al., 1985) . This contrasts with the original studies where cell-grown viruses had been passaged a maximum of five times and is supported by the observation that non-ts PP330/1, passaged up to seven times in tissue culture as the ts mutants were, was fully virulent after one mouse passage (Table 2 ). This may also explain the reduced virulence of the acyclovir-resistant mutants and the avirulence of ts6 (Table 2) which were derived from cell-grown virus (Sandford et al., 1985 ; Sandford & Burns, 1988) . Finally, although the presence of antibody does enhance the virulence of cell-grown virus passaged 10 to 20 times, it does not fully restore virulence to that of SGV (Inada et al., 1985; Inada & Mims, 1985) . Together these observations clearly suggest that factors in addition to virion-bound non-neutralizing antibody acquired in vivo are involved in MCMV virulence.
It is of interest to speculate on how the ts phenotype may be expressed in vivo. In general there is a reasonable correlation between the level of plaque formation and/or replication restriction in vitro and the virulence of the virus. Thus PP269/38 is incapable of replicating or forming plaques in vitro at 39 °C, does not replicate in 1-week-old mice and is consequently avirulent. Similarly, PP392/31, which is restricted at 40 °C but replicates as well as SGV at 39 °C in vitro, replicates to high titre in vivo and is the least attenuated of the ts mutants. However two other mutants, PP268/38 and PP99/3, have similar in vitro characteristics in that no detectable virus is released into the medium at 40 °C, they replicate only poorly at 39 °C and produce plaques of reduced size at 40 °C, but nevertheless exhibit 10-fold differences in virulence (Table 2 ). These differences in virulence are of the same magnitude as those observed for susceptible (BALB/c; H-2 d) and resistant (B10. BR, C3H; H-2 k) strains of mice (Shellam & Flexman, 1986) . This suggests that factors other than or additional to the temperature sensitivity may play a role. In this respect it is interesting that ts mutants of echovirus 9 were attenuated for newborn mice although such mice have body temperatures permissive for growth of the mutants (Rosenwirth et al., 1988) .
A comparison of parental virus and ts mutants with a 100-fold difference in virulence may help to elucidate virus functions or virion components involved in latency, reactivation, immunosuppression and interstitial pneumonitis. It remains to be seen whether the mutants generated in this study prove to be useful in studies of any of these aspects of virulence. It is interesting that ts6, although replicating only poorly in vivo, entered into the latent state and could be reactivated 1 year later as ts virus (Sandford & Burns, 1988) . Clearly the ts lesion in ts6 was not in a gene whose product is important in initiating and maintaining latency. Further work is under way to map physically the ts mutations in MCMV and to determine the genetic functions that are impaired.
